CO2023007156A2 - Cápsulas de gel blando de liberación retardada - Google Patents

Cápsulas de gel blando de liberación retardada

Info

Publication number
CO2023007156A2
CO2023007156A2 CONC2023/0007156A CO2023007156A CO2023007156A2 CO 2023007156 A2 CO2023007156 A2 CO 2023007156A2 CO 2023007156 A CO2023007156 A CO 2023007156A CO 2023007156 A2 CO2023007156 A2 CO 2023007156A2
Authority
CO
Colombia
Prior art keywords
soft gel
gel capsules
delayed release
release soft
release
Prior art date
Application number
CONC2023/0007156A
Other languages
English (en)
Spanish (es)
Inventor
Qi Fang
Karunakar Sukuru
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2023007156A2 publication Critical patent/CO2023007156A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CONC2023/0007156A 2020-11-11 2023-05-30 Cápsulas de gel blando de liberación retardada CO2023007156A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063112456P 2020-11-11 2020-11-11
PCT/US2021/072325 WO2022104338A1 (en) 2020-11-11 2021-11-10 Delayed release softgel capsules

Publications (1)

Publication Number Publication Date
CO2023007156A2 true CO2023007156A2 (es) 2023-06-20

Family

ID=81601781

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0007156A CO2023007156A2 (es) 2020-11-11 2023-05-30 Cápsulas de gel blando de liberación retardada

Country Status (13)

Country Link
US (1) US20230404927A1 (cg-RX-API-DMAC10.html)
EP (1) EP4243786A4 (cg-RX-API-DMAC10.html)
JP (2) JP7830458B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230106641A (cg-RX-API-DMAC10.html)
CN (1) CN116685311A (cg-RX-API-DMAC10.html)
AR (1) AR124044A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021377907A1 (cg-RX-API-DMAC10.html)
CA (1) CA3197516A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023007156A2 (cg-RX-API-DMAC10.html)
IL (1) IL302751A (cg-RX-API-DMAC10.html)
MX (1) MX2023005450A (cg-RX-API-DMAC10.html)
TW (1) TW202233165A (cg-RX-API-DMAC10.html)
WO (1) WO2022104338A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung
AU2023292098A1 (en) * 2022-06-13 2025-01-16 R.P. Scherer Technologies, Llc Enteric bisacodyl softgel capsule
KR102785453B1 (ko) * 2022-06-21 2025-03-26 우리바이오(주) 장용성 연질 캡슐용 겔 매스 조성물
WO2024035910A1 (en) * 2022-08-12 2024-02-15 R.P. Scherer Technologies, Llc Coated enteric softgel capsules
AU2023397554B2 (en) 2022-12-14 2026-01-29 R.P. Scherer Technologies, Llc Softgel capsules and a method for preparing the softgel capsules
JPWO2025009342A1 (cg-RX-API-DMAC10.html) * 2023-07-03 2025-01-09
CN120436302A (zh) * 2024-02-08 2025-08-08 仙乐健康科技(广东)有限公司 一种果胶凝胶及其制备方法
WO2025234509A1 (ko) * 2024-05-08 2025-11-13 코스맥스바이오 주식회사 pH 의존성 필름 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0427352A (ja) * 1990-05-22 1992-01-30 Fuji Capsule Kk 健康食品用腸溶性軟カプセル
US5342626A (en) * 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US20120301546A1 (en) 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
TW201343203A (zh) * 2011-12-22 2013-11-01 普諾華生物製藥諾治股份有限公司 含有ω-3脂肪酸之經明膠/藻酸鹽延緩釋放型膠囊,其製法及用途
MX2014011139A (es) * 2012-04-13 2015-07-17 Banner Life Sciences Llc Cápsulas elásticas blandas que contienen comprimidos y rellenos líquidos o semisólidos y métodos para su fabricacion.
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
MY184967A (en) 2014-10-06 2021-04-30 Fuji Capsule Co Ltd Method of producing enteric soft capsule
US10711119B2 (en) * 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
EP3768094B1 (en) 2018-03-15 2024-05-01 R.P. Scherer Technologies, LLC Enteric softgel capsules

Also Published As

Publication number Publication date
KR20230106641A (ko) 2023-07-13
JP2023549177A (ja) 2023-11-22
WO2022104338A1 (en) 2022-05-19
IL302751A (en) 2023-07-01
US20230404927A1 (en) 2023-12-21
EP4243786A1 (en) 2023-09-20
TW202233165A (zh) 2022-09-01
JP2026086913A (ja) 2026-05-26
CN116685311A (zh) 2023-09-01
MX2023005450A (es) 2023-05-23
EP4243786A4 (en) 2024-10-23
AR124044A1 (es) 2023-02-08
AU2021377907A1 (en) 2023-06-15
CA3197516A1 (en) 2022-05-19
JP7830458B2 (ja) 2026-03-16

Similar Documents

Publication Publication Date Title
AR124044A1 (es) Cápsulas blandas de liberación retardada
AR119075A1 (es) Cápsulas blandas de liberación diferida
AR100519A1 (es) Envase tipo cápsula de gelatina blanda y su método de fabricación
CL2021003306A1 (es) Agentes, usos y métodos para el tratamiento de la sinucleinopatía. (divisional de solicitud nº 201901293)
CO2023007162A2 (es) Cápsulas de gelatina blanda de liberación retardada
CL2020002840A1 (es) Compuestos inhibidores de rip1 y métodos para preparar y usar los mismos
SV2018005638A (es) Envase blister
CR20180228A (es) Terapia adjunta con 25-hidroxi vitamina d y articulos de la misma
AR115269A1 (es) Cápsulas de gelatina blanda entéricas
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
CL2019000665A1 (es) Lixiviación en pilas (divisional solicitud 201801080)
AR120326A1 (es) CÁPSULAS DE GEL BLANDO DE LIBERACIÓN RETARDADA EN AMBIENTE DE pH ALTO
CR20170142A (es) Composiciones farmacéuticas resistentes al abuso
AR122512A1 (es) Cápsulas blandas de liberación retardada
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
AR123805A1 (es) Cápsulas blandas de liberación modificada
MX2025014063A (es) Inhibidores de expresion y/o funcion
CL2021003286A1 (es) Cápsula de tipo desintegración retardada y método para producir la misma.
AR119414A1 (es) Cápsula blanda de gelatina entérica de inhibidor de la bomba de protones
MX360662B (es) Formulación de liberación plurimodal de doxilamina y piridoxina y/o metabolitos o sales de las mismas.
PE20211376A1 (es) Agente terapeutico o profilactico para la mielopatia asociada al htlv-1 (ham), y metodo de tratamiento del ham
BR112021015795A8 (pt) Composição
MX2020005697A (es) Capsula blanda de gel liquido de doble camara y metodo para administrar composiciones de cannabis sublinguales e ingeribles.
AR130183A1 (es) Cápsulas blandas entéricas recubiertas
AR131366A1 (es) Cápsulas de gelatina blanda y método de preparación de las cápsulas de gelatina blanda